Transpek Industry Limited has received approval from BSE Limited to reclassify shareholder Malti Dilipsinh Bhatia from the promoter category to the public category. The reclassification, effective following the stock exchange's no-objection, reduces the promoter group's holding by 10,800 shares, which constitutes 0.19% of the company's total share capital.

The approval was communicated via BSE letter reference LIST/COMP/KR/081/2026-27 dated June 1, 2026. This decision follows the company's application submitted on February 10, 2026, seeking the change in status for the shareholder in accordance with Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Reclassification Details

The following table outlines the specific changes in shareholding status resulting from this regulatory approval:

The company has confirmed that it will ensure compliance with all subsequent disclosures required under Regulation 31A of the SEBI LODR Regulations regarding this material event. The information is now available on the company's official website.

Transpek Industry Limited reported a decline in consolidated net profit for the financial year ended March 31, 2026, while its Board of Directors recommended a dividend of ₹20 per equity share. The company recorded a consolidated net profit of ₹4,564.54 lakh for FY26, compared to ₹4,873.70 lakh in the previous year. Revenue from operations for the year stood at ₹6,211.99 crore, down from ₹6,498.53 crore in FY25. The Board approved the audited financial results for the quarter and year ended March 31, 2026, during its meeting on May 26, 2026.

The statutory auditor, Bansi S. Mehta & Co., provided an unmodified opinion on the standalone and consolidated financial results, confirming compliance with Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The auditors confirmed that the statements present a true and fair view in conformity with Indian Accounting Standards. The consolidated financial results incorporate data from Transpek Creative Chemistry Private Limited, a wholly owned subsidiary.

Q4 Performance: Profitability Under Pressure

For the quarter ended March 31, 2026, Transpek Industry's operational profitability deteriorated sharply on a year-on-year basis. Q4 EBITDA declined to ₹177M from ₹322M in the same period last year, while the EBITDA margin contracted significantly to 11.96% from 19.50% YoY. On a standalone basis, Q4 net profit fell to ₹66M from ₹193M YoY, and Q4 revenue came in at ₹1.5B compared to ₹1.65B in the corresponding period. On a consolidated basis, the company reported a net profit of ₹658.03 lakh for the quarter, a decrease from ₹1,925.13 lakh in the same period last year, with consolidated revenue at ₹1,482.15 crore versus ₹1,652.57 crore in Q4FY25. Total expenses for the quarter amounted to ₹1,436.55 crore.

The following table summarises the key Q4 metrics on a year-on-year basis:

Dividend and AGM Details

The Board has fixed the Annual General Meeting for September 15, 2026, at 3.00 p.m. via video conferencing. The recommended dividend of ₹20 per share, amounting to 200% of the face value of ₹10, is subject to shareholder approval at the AGM. If approved, the dividend will be paid within 30 days of the declaration. The company's earnings per share (EPS) for the year stood at ₹81.72 on a consolidated basis, down from ₹87.25 in the previous year. The trading window, which had been closed since April 1, 2026, is set to reopen on May 28, 2026.

Financial Summary for FY26

The table below presents the key annual financial metrics for FY26 on both a standalone and consolidated basis: